win 52035 and win 52084

win 52035 has been researched along with win 52084 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diana, GD; Dutko, FJ; Kowalczyk, P; Oglesby, RC; Pevear, DC; Treasurywala, AM1
Bailey, TR; Diana, GD; Dutko, FJ; Oglesby, RC; Pevear, DC; Treasurywala, AM1
Akullian, V; Diana, GD; McKinlay, MA; Oglesby, C; Otto, MJ1
Egorova, A; Ekins, S; Makarov, V; Schmidtke, M1
Badger, J; Dutko, FJ; Fancher, M; Heinz, BA; McKinlay, MA; Rossmann, MG; Rueckert, RR; Shepard, DA; Smith, TJ1
Hadfield, AT; Heinz, BA; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Pevear, DC; Rossmann, MG; Rueckert, RR; Shepard, D1
Blaas, D; Kenndler, E; Nizet, S; Okun, VM1

Reviews

1 review(s) available for win 52035 and win 52084

ArticleYear
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
    European journal of medicinal chemistry, 2019, Sep-15, Volume: 178

    Topics: Antiviral Agents; Binding Sites; Capsid; Dose-Response Relationship, Drug; Enterovirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2019

Other Studies

6 other study(ies) available for win 52035 and win 52084

ArticleYear
CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
    Journal of medicinal chemistry, 1992, Mar-20, Volume: 35, Issue:6

    Topics: Antiviral Agents; Binding Sites; Humans; Isoxazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Rhinovirus; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction

1992
A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:5

    Topics: Antiviral Agents; Binding Sites; Capsid; Isoxazoles; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Rhinovirus; Structure-Activity Relationship; X-Ray Diffraction

1990
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:12

    Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Isoxazoles; Mice; Oxazoles; Picornaviridae Infections; Poliovirus; Rhinovirus; Structure-Activity Relationship; Time Factors; Virus Replication

1985
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
    Journal of virology, 1989, Volume: 63, Issue:6

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Molecular Conformation; Molecular Structure; Mutation; Oxazoles; Rhinovirus; Viral Plaque Assay

1989
Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
    Journal of molecular biology, 1995, Oct-13, Volume: 253, Issue:1

    Topics: Antiviral Agents; Binding, Competitive; Capsid; Crystallography, X-Ray; Drug Resistance, Microbial; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Mutation; Protein Conformation; Receptors, Virus; Rhinovirus; Viral Proteins

1995
Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis.
    Electrophoresis, 2002, Volume: 23, Issue:6

    Topics: Antiviral Agents; Benzoates; Capsid; Electrophoresis, Capillary; Heating; HeLa Cells; Humans; Isoelectric Point; Isoxazoles; Kinetics; Pyrroles; Rhinovirus; Temperature; Time Factors

2002